期刊文献+

肿瘤特异性调控元件在基因治疗中的研究进展 被引量:2

下载PDF
导出
摘要 肿瘤自杀基因疗法,要求目的基因选择性地表达于肿瘤靶细胞中,方能准确地杀伤肿瘤细胞,保护正常组织,减少毒副作用,特别是随着药物的旁杀作用愈来愈强,对基因表达的肿瘤细胞特异性的要求就显得尤为重务。本文就肿瘤特异性调控元件在基因治疗中的研究进展作一综述,并对将采可能出现的肿瘤基因治疗模式作一展望。
作者 谢庆军
出处 《国外医学(肿瘤学分册)》 北大核心 1997年第5期273-275,共3页 Foreign Medical Sciences (Cancer Section)
  • 相关文献

同被引文献28

  • 1Seo SY,Chen YB,Ivanovska I,et al.BAD Is a Pro-survival factor prior to activation of its pro-apoptotic function.J Biol Chem,2004,279(40):42240.
  • 2Verhaegh ME,Sanders CJ,Arends JW,et al.Expression of apoptosis-suppressing protein Bcl-2 in non-melanoma skin cancer.Br J Dermato1,1995,139(5):740.
  • 3Morales-Ducret CR,Van de Rijn M,Smoller BR,et al.Bcl-2 expression in primary malignancies of the skin.Arch Dermatol,1995,131(8):909.
  • 4Gross A,McDonnell JM,Korsmeyer SJ.BCL-2 family members and the mitochondria in apoptosis.Genes Dev,1999,3(15):1899.
  • 5Ramdial PK,Madaree A,Reddy R,et al.Bcl-2 protein expression in aggressive and non-aggressive basal cell carcinomas.J Cutan Pathol,2000,27(6):283.
  • 6Tomkova H,Fujimoto W,Arata J.Expression of the bcl-2 homologue bax in normal human skin,psoriasis vulgaris and non-melanoma skin cancers.Eur J Dermatol,1998,8(4):256.
  • 7Korsmeyer SJ.BCL-2 gene family and the regulation of programmed cell death.Cancer Res,1999,59(7 Suppl):1693s.
  • 8Fang X,Yu S,Eder A,et al.Regulation of BAD phosphorylation at serine 112 by the Ras-mitogen-activated protein kinase pathway.Oncogene,1999,18(48):6635.
  • 9DescampsY,DuffourMT,MathieuMC,etal.Strategiesforcancergenetherapyusimgadenoviralvectors[J].MolMed,1996,74:183
  • 10GutierrezAA,LemoineNR,SikoreK.Genetherapyofcancer[J].Lancet,1999,339:715

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部